10:59:40Australia

Bio-Techne Corp (TECH)

NASDAQ

Key stats Fiscal year 2026

Income statement

Revenue
1,215,039,000 -0.4%
Net income
181,862,000 147.8%
Gross profit
799,071,000
Operating income
251,890,000
Earnings per share
1.17 148.9%

Growth and profitability

Gross margin
65.77
Operating margin
20.73
Net margin
14.97
Return on equity
8.63
Return on assets
7.03
Free cash flow margin
21.66

Balance sheet

Total assets
2,586,726,000
Shareholders' equity
2,108,221,000
Cash and equivalents
264,712,000
Current ratio
4.55

Cash flow and ratios

Operating cash flow
292,073,000
Free cash flow
263,223,000

Shareholder returns

Dividend per share
0.32
Dividends paid
49,916,000
Share buybacks
41,675,000
Shares outstanding
157,090,727
Book value per share
13.42
Revenue and net income
From revenue to profit 2026
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Minneapolis, MN
Exchange
NASDAQ
Fiscal year end
06-30
Industry (SEC)
Biological Products, (no Diagnostic Substances)

Fiscal year end: · Source: SEC EDGAR

Bio-Techne Corp trades on NASDAQ under the ticker symbol TECH. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis